Old Web
English
Sign In
Acemap
>
Paper
>
Nilotinib appears beneficial in phase I study for patients with Gleevec-resistant CML
Nilotinib appears beneficial in phase I study for patients with Gleevec-resistant CML
2006
Hagop M. Kantarjian
Francis J. Giles
Susan O'Brien
Jorge E Cortes
Oliver G. Ottmann
Lydia Wunderle
Barbara Wassmann
Dieter Hoelzer
Chiaki Tanaka
Paul W. Manley
Patricia Rae
William Mietlowski
Kathy Bochinski
Margaret Dugan
Leila Alland
Andreas Hochhaus
Kapil Bhalla
Maher Albitar
James D. Griffin
Keywords:
Nilotinib
Biology
Cancer research
phase i study
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]